speb/financial-data huggingface dataset:
ALS.DE income_statement (quarterly, 2025-09-30) — Loss Adjustment Expense: 8721000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Minimum Pension Liabilities: 10000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Minority Interest: -16000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Minority Interests: 2000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 1219000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -360000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Net Debt: 7158000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income: 3746000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3717000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3744000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3746000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3746000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3744000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3744000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Interest Income: -101000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -3945000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -101000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 7000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Net PPE: 601000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -48000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Net Policyholder Benefits And Claims: 8721000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 24387000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 311000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 311000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Normalized Income: 3199769000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3284000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1074000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Operating Revenue: 17061000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 262139366.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Other Cash Adjustment Outside Changein Cash: 91000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 354000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Other Income Expense: 691000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 2265000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 8743000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Other Special Charges: -720000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -108000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 82000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 2001000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: -29000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 29000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 2001000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Pretax Income: 4819000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 12000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -271000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -30220000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -48000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Receivables: 21264000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 115000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: 0.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -360000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 17000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 58853000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Salaries And Wages: -108000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Sale Of Business: 1490000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 26275000000.00
ALS.DE cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
ALS.DE income_statement (quarterly, 2025-09-30) — Selling General And Administration: -108000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Share Issued: 900139366.00
ALS.DE income_statement (quarterly, 2025-09-30) — Special Income Charges: 703000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 27505000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 22386000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 156769000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Tax Provision: 1075000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.22
ALS.DE balance_sheet (quarterly, 2025-09-30) — Total Assets: 120402000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 35594000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Total Debt: 8089000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 27489000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Total Expenses: 12242000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 92913000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items: 703000000.00
ALS.DE income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 703000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 638000000.00
ALS.DE balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 37773000000.00
ALS.DE income_statement (annual, 2025-12-31) — +Total Revenue: 67069000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — +Total Revenue: 17199000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 19975000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 19975000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 4158000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 4158000000.00
ALS.DE income_statement (annual, 2025-12-31) — Amortization: 231000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Amortization: 56000000.00
ALS.DE income_statement (annual, 2025-12-31) — Basic Average Shares: 263600000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Basic Average Shares: 261300000.00
ALS.DE income_statement (annual, 2025-12-31) — Basic EPS: 38.56
ALS.DE income_statement (quarterly, 2025-12-31) — Basic EPS: 14.55
ALS.DE cash_flow (annual, 2025-12-31) — Beginning Cash Position: 704000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 931000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Capital Expenditure: -228000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -89000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Capital Stock: 2010000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2010000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 678000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 678000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5565000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5565000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1153000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -292000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -2881000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1293000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7255000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1949000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10110000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2989000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 221000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 51000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Change In Receivables: -201000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Change In Receivables: 1306000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Change In Working Capital: 832000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -875000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -201000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 1306000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Changes In Cash: -26000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Changes In Cash: -253000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Common Stock: 9000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Common Stock: 9000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -1036000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -263000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Common Stock Equity: 28609000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 28609000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Common Stock Payments: -1233000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -434000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Current Debt: 550000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Current Debt: 550000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 550000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 550000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Current Notes Payable: 550000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Current Notes Payable: 550000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Depreciation: 482000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Depreciation: 108000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 482000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 108000000.00
ALS.DE income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 231000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 56000000.00
ALS.DE income_statement (annual, 2025-12-31) — Diluted Average Shares: 267100000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 264700000.00
ALS.DE income_statement (annual, 2025-12-31) — Diluted EPS: 38.06
ALS.DE income_statement (quarterly, 2025-12-31) — Diluted EPS: 14.37
ALS.DE income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 10165000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3803000000.00
ALS.DE income_statement (annual, 2025-12-31) — EBIT: 13555000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — EBIT: 5013000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 18000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -6000000.00
ALS.DE cash_flow (annual, 2025-12-31) — End Cash Position: 678000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — End Cash Position: 678000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Financing Cash Flow: -2881000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1293000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -55000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -55000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Free Cash Flow: 9882000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 2900000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 74000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -65000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -1603000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of Business: 7000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 255000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 255000000.00
ALS.DE income_statement (annual, 2025-12-31) — General And Administrative Expense: -35000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — General And Administrative Expense: -5000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Goodwill: 3118000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Goodwill: 3118000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 3676000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 3676000000.00
ALS.DE income_statement (annual, 2025-12-31) — Interest Expense: 399000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Interest Expense: 98000000.00
ALS.DE income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 399000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 98000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Invested Capital: 36099000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Invested Capital: 36099000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Investing Cash Flow: -7255000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1949000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Investments And Advances: 81244000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 81244000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 8844000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 8844000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
ALS.DE cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
ALS.DE balance_sheet (annual, 2025-12-31) — Loans Receivable: 473000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 473000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Long Term Debt: 6940000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 6940000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6940000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6940000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
ALS.DE cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -600000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -600000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 8844000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 8844000000.00
ALS.DE income_statement (annual, 2025-12-31) — Loss Adjustment Expense: 38110000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Loss Adjustment Expense: 7804000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Minimum Pension Liabilities: 11000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Minimum Pension Liabilities: 11000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Minority Interest: -21000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Minority Interest: -21000000.00
ALS.DE income_statement (annual, 2025-12-31) — Minority Interests: 16000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Minority Interests: 5000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 3129000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 108000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -1233000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -434000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Net Debt: 6812000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Net Debt: 6812000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income: 10282000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income: 3832000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 10165000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3803000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 10266000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3827000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 10282000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3832000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 10282000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3832000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 10266000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 3827000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 10266000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3827000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Interest Income: -399000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Interest Income: -98000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -10041000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1906000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -600000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -600000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -600000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -399000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -98000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 57000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 23000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Net PPE: 627000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Net PPE: 627000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -228000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -89000000.00
ALS.DE income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 38110000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 7804000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 0.00
ALS.DE balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 26934000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 26934000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 227000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 227000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 227000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 227000000.00
ALS.DE income_statement (annual, 2025-12-31) — Normalized Income: 9079240000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Normalized Income: 3847572736.52
ALS.DE cash_flow (annual, 2025-12-31) — Operating Cash Flow: 10110000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 2989000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Operating Gains Losses: -1546000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -69000000.00
ALS.DE income_statement (annual, 2025-12-31) — Operating Revenue: 67069000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Operating Revenue: 17199000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 260135910.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 260135910.00
ALS.DE balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 299000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 299000000.00
ALS.DE income_statement (annual, 2025-12-31) — Other Income Expense: 2955000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Other Income Expense: 755000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 558000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 558000000.00
ALS.DE income_statement (annual, 2025-12-31) — Other Operating Expenses: 8977000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 2332000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 4887000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4887000000.00
ALS.DE income_statement (annual, 2025-12-31) — Other Special Charges: -1603000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Other Special Charges: 7000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -35000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: -5000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Preferred Shares Number: 82000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Preferred Shares Number: 82000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Preferred Stock: 2001000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 2001000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -117000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -29000000.00
ALS.DE income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 117000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 29000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 2001000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 2001000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 0.00
ALS.DE cash_flow (annual, 2025-12-31) — Preferred Stock Payments: 0.00
ALS.DE income_statement (annual, 2025-12-31) — Pretax Income: 13156000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Pretax Income: 4915000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 48000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 10000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Purchase Of Business: -1269000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -308000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Purchase Of Investment: -90779000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -18998000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Purchase Of PPE: -228000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -89000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Receivables: 19975000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Receivables: 19975000000.00
ALS.DE income_statement (annual, 2025-12-31) — Reconciled Depreciation: 482000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 108000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Repayment Of Debt: -600000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -600000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1233000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -434000000.00
ALS.DE income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 61000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 13000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Retained Earnings: 62393000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 62393000000.00
ALS.DE income_statement (annual, 2025-12-31) — Salaries And Wages: -35000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Salaries And Wages: -5000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Sale Of Business: 4398000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Sale Of Business: 416000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Sale Of Investment: 80738000000.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 17092000000.00
ALS.DE cash_flow (annual, 2025-12-31) — Sale Of PPE: 0.00
ALS.DE cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
ALS.DE income_statement (annual, 2025-12-31) — Selling General And Administration: -35000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Selling General And Administration: -5000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Share Issued: 900135910.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Share Issued: 900135910.00
ALS.DE income_statement (annual, 2025-12-31) — Special Income Charges: 1542000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Special Income Charges: -20000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Stockholders Equity: 30610000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 30610000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Tangible Book Value: 24933000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 24933000000.00
ALS.DE income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 339240000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -4427263.48
ALS.DE income_statement (annual, 2025-12-31) — Tax Provision: 2890000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Tax Provision: 1088000000.00
ALS.DE income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
ALS.DE income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.22
ALS.DE balance_sheet (annual, 2025-12-31) — Total Assets: 119758000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Total Assets: 119758000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Total Capitalization: 37550000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 37550000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Total Debt: 7490000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Total Debt: 7490000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 30589000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 30589000000.00
ALS.DE income_statement (annual, 2025-12-31) — Total Expenses: 53913000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Total Expenses: 12284000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 89169000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 89169000000.00
ALS.DE income_statement (annual, 2025-12-31) — Total Unusual Items: 1542000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items: -20000000.00
ALS.DE income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1542000000.00
ALS.DE income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -20000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 640000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 640000000.00
ALS.DE balance_sheet (annual, 2025-12-31) — Treasury Stock: 38206000000.00
ALS.DE balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 38206000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — +Total Revenue: 16751000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 20070000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4169000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Amortization: 47000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Basic Average Shares: 259400000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Basic EPS: 9.36
ALS.DE cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 678000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -40000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2010000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 697000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5402000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -290000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -916000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2627000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 3562000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 520000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Change In Receivables: -112000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 579000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -112000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Changes In Cash: 19000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Common Stock: 9000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -261000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 29606000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -614000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Depreciation: 101000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 101000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 47000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 262600000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Diluted EPS: 9.25
ALS.DE income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2428000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — EBIT: 3206000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 16000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — End Cash Position: 697000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -916000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -83000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3522000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 383000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -292000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 19000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Goodwill: 3118000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 3118000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Interest Expense: 98000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 98000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Invested Capital: 37097000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2627000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 83142000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 8946000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 520000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 7491000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 7491000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 8946000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 9261000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Minimum Pension Liabilities: 10000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Minority Interest: -20000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Minority Interests: -1000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -40000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -614000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Net Debt: 6794000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income: 2457000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2428000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2458000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2457000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2457000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2458000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2458000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Interest Income: -98000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -2557000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -98000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -4000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Net PPE: 606000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -40000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 9261000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 28489000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Normalized Income: 2460954311.45
ALS.DE cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 3562000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 418000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Operating Revenue: 16751000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 257800000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 0.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -219000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Other Income Expense: 719000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 2225000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4705000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 19000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 82000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 2001000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -29000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 29000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 2001000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Pretax Income: 3108000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: -8000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -386000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -28562000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -40000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Receivables: 20070000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 101000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -614000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 5000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 64540000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Salaries And Wages: 19000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Sale Of Business: 346000000.00
ALS.DE cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 26005000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Selling General And Administration: 19000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Share Issued: 899800000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Special Income Charges: -5000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 31607000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 26488000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -1045688.55
ALS.DE income_statement (quarterly, 2026-03-31) — Tax Provision: 650000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
ALS.DE balance_sheet (quarterly, 2026-03-31) — Total Assets: 123972000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 39098000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Total Debt: 7491000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 31587000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Total Expenses: 13643000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 92385000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items: -5000000.00
ALS.DE income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -5000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 642000000.00
ALS.DE balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 38820000000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -99855000.00
ALS.TO cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 22913000.00
ALS.TO cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 22913000.00
ALS.TO income_statement (annual, 2021-12-31) — Basic Average Shares: 41449386.00
ALS.TO income_statement (annual, 2021-12-31) — Basic EPS: 0.97
ALS.TO balance_sheet (annual, 2021-12-31) — Current Debt: 8000000.00
ALS.TO cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 22913000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 11000.00
ALS.TO income_statement (annual, 2021-12-31) — Diluted Average Shares: 42649410.00
ALS.TO income_statement (annual, 2021-12-31) — Diluted EPS: 0.94
ALS.TO income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
ALS.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 6031000.00
ALS.TO income_statement (annual, 2021-12-31) — Interest Income: 18016000.00
ALS.TO income_statement (annual, 2021-12-31) — Interest Income Non Operating: 18016000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 1620000.00
ALS.TO cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
ALS.TO cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
ALS.TO balance_sheet (annual, 2021-12-31) — Net Debt: 7152000.00
ALS.TO income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 472000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Preferred Shares Number: 10000000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Preferred Stock: 57061000.00
ALS.TO cash_flow (annual, 2021-12-31) — Preferred Stock Dividend Paid: -5000000.00
ALS.TO balance_sheet (annual, 2021-12-31) — Preferred Stock Equity: 57061000.00
ALS.TO income_statement (annual, 2022-12-31) — +Operating Expense: 14120000.00
ALS.TO income_statement (annual, 2022-12-31) — +Total Revenue: 102047000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 5642000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 10937000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -121196000.00
ALS.TO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 24292000.00
ALS.TO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 24292000.00
ALS.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 84000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 218210000.00
ALS.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 45855383.00
ALS.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.82
ALS.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 100021000.00
ALS.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -2335000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 358697000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 82385000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 82385000.00
ALS.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -16489000.00
ALS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -10751000.00
ALS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -85750000.00
ALS.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 74260000.00
ALS.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 457000.00
ALS.TO cash_flow (annual, 2022-12-31) — Change In Receivables: 1295000.00
ALS.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: 1752000.00
ALS.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: 1295000.00
ALS.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -22241000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Common Stock: 358697000.00
ALS.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -13143000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 486193000.00
ALS.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -4835000.00
ALS.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 30165000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Current Assets: 104143000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 8000000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 19688000.00
ALS.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 12374000.00
ALS.TO cash_flow (annual, 2022-12-31) — Deferred Tax: 12374000.00
ALS.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 24292000.00
ALS.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 24292000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
ALS.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 47151148.00
ALS.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.80
ALS.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 37489000.00
ALS.TO income_statement (annual, 2022-12-31) — EBIT: 58875000.00
ALS.TO income_statement (annual, 2022-12-31) — EBITDA: 83167000.00
ALS.TO income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 1828000.00
ALS.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -1828000.00
ALS.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 4605000.00
ALS.TO cash_flow (annual, 2022-12-31) — End Cash Position: 82385000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Financial Assets: 2148000.00
ALS.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -10751000.00
ALS.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 71925000.00
ALS.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1098000.00
ALS.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -2166000.00
ALS.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 2082000.00
ALS.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -2797000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 102843000.00
ALS.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 13919000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 228321000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 10129000.00
ALS.TO income_statement (annual, 2022-12-31) — Gross Profit: 71882000.00
ALS.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
ALS.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 6046000.00
ALS.TO income_statement (annual, 2022-12-31) — Interest Expense: 7019000.00
ALS.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 7019000.00
ALS.TO income_statement (annual, 2022-12-31) — Interest Income: 17846000.00
ALS.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 17846000.00
ALS.TO cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -6552000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 599066000.00
ALS.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -85750000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 218210000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 429070000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 1613000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 209247000.00
ALS.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 10000000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Loans Receivable: 6773000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 112873000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 112873000.00
ALS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 10000000.00
ALS.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -8168000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 210860000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 122616000.00
ALS.TO income_statement (annual, 2022-12-31) — Minority Interests: -1993000.00
ALS.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -30281000.00
ALS.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -4835000.00
ALS.TO balance_sheet (annual, 2022-12-31) — Net Debt: 30488000.00
ALS.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 3167000.00
ALS.TO income_statement (annual, 2022-12-31) — Net Income: 37489000.00
ALS.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 37489000.00
ALS.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 39482000.00
ALS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 37489000.00
ALS.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 37489000.00
ALS.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 39482000.00